Pharmanutra S.p.A.
MIL: PHN.MI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Italian Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Andrea Lacorte
- Employees
- 118
- Headquarters
- Pisa, Italy
- IPO year
- 2017
- Market cap
- €743.0M
- Website
- https://www.pharmanutra.it
Loading PHN…
Loading profile data…Frequently asked questions about PHN
What does Pharmanutra S.p.A. (PHN.MI) do?
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sec...
Where does PHN.MI trade?
Pharmanutra S.p.A. (PHN.MI) trades on the Italian Stock Exchange.
What sector is PHN.MI in?
Pharmanutra S.p.A. (PHN.MI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Pharmanutra S.p.A.?
Andrea Lacorte is the chief executive officer of Pharmanutra S.p.A. (PHN.MI).
Where is Pharmanutra S.p.A. headquartered?
Pharmanutra S.p.A. is headquartered in Italy.
Does PHN.MI pay a dividend?
Yes — Pharmanutra S.p.A. (PHN.MI) paid a trailing twelve-month dividend of EUR 1.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did PHN.MI go public?
Pharmanutra S.p.A. (PHN.MI) completed its initial public offering in 2017.